2019

10/10/2019 Guerbet signs an agreement with icometrix for the exclusive distribution of icobrain, an artificial intelligence medical imaging solution for neuro imaging

Villepinte (France) – October 10, 2019 (8:30 CEST) – Guerbet, a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, today announced that it has signed an exclusive agreement with icometrix for the distribution in France, Italy and Brazil of...

[more]


10/09/2019 Guerbet to participate in the 75th annual meeting of the ASRM (American Society for Reproductive Medicine)

Guerbet will participate in the 75th annual meeting of the American Society for Reproductive Medicine (ASRM). This year’s ASRM Scientific Congress & Expo theme is “Celebrating 75 Years of History and Innovation” in keeping with their anniversary and the critical role of ASRM in focusing on the...

[more]


09/25/2019 2019 half-year results

Activity growth  › Reported revenue of €400.6 million, up 2.8%, in line with the annual objectives › Revenue of €396.5 million at constant exchange rates, up 1.8% Results in line with GEAR 2023 › €61.6 million EBITDA, including significant expenditures to prepare for the...

[more]


09/24/2019 Guerbet and IBM Watson Health announce a second co-development project as part of their strategic partnership for leveraging artificial intelligence in medical imaging

This second agreement is aimed at developing and marketing a software solution to help radiologists and oncologists diagnose and monitor prostate cancer

[more]


08/29/2019 Guerbet to present its innovative solution offering for interventional imaging at CIRSE 2019

An innovation lab with 2 dedicated demo rooms for Vectorio® and SeQure®;SeQure® microcatheter pre-clinical data presentation;2 symposia in Oncology and Vascular Embolization. Villepinte (France) – August 29, 2019 - 06:00pm (CEST) - Guerbet (FR0000032526 GBT), a global specialist of contrast...

[more]


07/25/2019 Revenue at 30 June 2019

Revenue of €400.6 million for the 1st half of the year, in line with annual targets: • +2.8% at current exchange rates• +1.8% at constant exchange rates Villepinte, 25 July 2019 – Guerbet (FR0000032526 GBT), a global specialist in contrast agents and solutions for medical imaging, today...

[more]


07/16/2019


Displaying results 1 to 7 out of 21
<< First < Previous 1-7 8-14 15-21 Next > Last >>